Articles published by Telix Pharmaceuticals Limited
TLX101-Px (Pixlumi®) MAA Accepted in Europe
April 30, 2026
FDA Accepts NDA for TLX101-Px (Pixclara®)
April 09, 2026
Telix Appoints David Gill as Non-Executive Director
April 01, 2026
Investor Education Webinar
March 01, 2026
Telix to Participate in Oppenheimer and TD Cowen Conferences
February 20, 2026
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
February 19, 2026
Telix Full Year Results 2025 Investor Webcast Notification
February 03, 2026
Telix to Participate in UBS and Jefferies Global Healthcare Conferences
November 05, 2025
Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain
October 22, 2025
Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded
October 14, 2025
CMS Grants Transitional Pass-Through Status for Gozellix
September 23, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.